The Benefits of moderate to high intensity multiple muscle electrical stimulation is based on solid and extensive research. The FDA electrical stimulator clearance describes the effects as increased regional blood flow, muscle re-education, reduced muscle spasms, pain management, and prevention of disuse muscle atrophy.
In contrast, the Neuro20 Pro system controls 20 electrodes and can be used for the trunk, hips and thighs linked together, or it can incorporate upper extremities, trunk muscles plus hip and thigh muscles connected through software programs. These programs can be pre-set or individually modified per each subject’s preference.
The combination of electrical stimulation applied to upper and lower extremities plus core muscles creates a synergy that improves coordination through sensory feedback as well as position awareness and increased muscle firing timing. Electrical currents delivered in a biphasic pattern that closely replicates the voluntary firing pattern of a specific motion, establishes muscle patterns and muscle memory.
- Improves Muscle Recruitment
- Bone Growth
- Muscle Injury Recovery
- Faster Reaction Times
- Sequential Muscle Firing Precision
- Synovial Fluid
- Local Blood Flow
- Tissue Temperature Muscle
- Lymphatic Drainage
- Flexibility / Range Of Motion
- Injury Recovery Time
- Muscle Spasms
- Muscle Atrophy
- Delayed Onset Muscle Soreness (DOMS)
Indications Of Use
Recover from Impaired Muscle Function
Relaxation of Muscle Spasms
Maintain or Increase Range of Motion
Prevention of Muscle Atrophy
Increase Local Blood Circulation
Improve Muscle Strength
Temporary Relief of Pain due to Sore/Aching Muscles
How it works
The Neuro20 Pro System is powerful, versatile, and tolerable. Depending on the timing and intensity, muscle re-education and increased local blood flow to the local muscles and joints occurs. This results in improved coordination and increased synovial fluid production as well as increased lubrication to the fibers of local tendons and ligaments, and oxygen and nutrients to the muscles.
This system further reduces spasms or muscle guarding around painful or injured areas. Guarding can occur from an acute injury, or post-operative or lingering pain from partially healed injuries. Local joint arthritis or inflammation can also create guarding. This leads to abnormal muscle firing patterns or diminished coordination as well as exercise intolerance due to pain in local tissue surrounding the injured area. Reduced exercise or uncoordinated muscle firing subsequently inhibits local blood flow and joint lubrication.
The Neuro20 Pro System stimulates the motor neuron to recruit the surrounding fibers without increasing the impact on the surrounding tissue and joints that occurs from traditional external exercise and rehabilitation programs. Joint dysfunction is improved as stimulation helps reduce the impact to the articulating surfaces through activating the surrounding muscles. Synovial fluid is also stimulated within each articular joint as the immediate regional muscles are repetitively activated, voluntarily or through stimulation.
The neurotransmitter that initiates muscle guarding is norepinephrine, which also inhibits local blood flow. This chemical is counteracted by acetylcholine that is responsible for muscle activation and local blood flow enhancement. Studies have shown that the increase in local blood flow as well as synovial lubrication begins after about five minutes of repeated muscle activation and increases multiple times after an additional ten minutes. This occurs both with voluntary as well as with electrical stimulation induced exercise. This is particularly important for recovery from musculoskeletal injuries or surgery to reduce disuse atrophy and enhance metabolic activity.
Pain reduction and amputee wound healing relies on increasing local blood flow and these are improved with specific NMES patterns. Four-channel stimulation applied to bilateral quads and hams has been shown to significantly improve function in patients unable to exercise due to chronic pulmonary disease – COPD.